Skip to main content
SpringerLink
Log in

GammaPod

  • Chapter
Principles and Practice of Stereotactic Radiosurgery

  • 2573 Accesses

Abstract

A dedicated stereotactic gamma irradiation device, GammaPod™ from Xcision Medical Systems, has been developed to treat early stage breast cancer. GammaPod™ offers the opportunity to deliver curative doses of radiation using stereotactic body radiotherapy (SBRT) more precisely than current radiotherapy standards, thereby minimizing the amount of breast tissue ablated and improving cosmesis. In this chapter, we review the current status of radiotherapy for breast cancer patients diagnosed with early stage disease and rationale for the development of a dedicated breast stereotactic system. Furthermore, a detailed description of the GammaPod technology, design specifications and its dosimetric characteristics are presented using comparative treatment planning studies in addition to dosimetric measurements from pre clinical prototype testing.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49.

    Article  PubMed  Google Scholar 

  2. Christian MC, McCabe MS, Korn EL, Abrams JS, Kaplan RS, Friedman MA. The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06. N Engl J Med. 1995;333:1469–74.

    Article  CAS  PubMed  Google Scholar 

  3. Knobf MT, Sun Y. A longitudinal study of symptoms and self-care activities in women treated with primary radiotherapy for breast cancer. Cancer Nurs. 2005;28:210–8.

    Article  PubMed  Google Scholar 

  4. Turnbull LW, Brown SR, Olivier C, Harvey I, Brown J, et al. Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision (COMICE). Health Technol Assess. 2010;14:1–182.

    Article  CAS  PubMed  Google Scholar 

  5. Bleicher RJ, Ciocca RM, Egleston BL, Sesa L, Evers K, Sigurdson ER, Morrow M. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg. 2009;209:180–7; quiz 294–5.

    Google Scholar 

  6. Kuhl C, Kuhn W, Braun M, Schild H. Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back? Breast. 2007;16 Suppl 2:S34–44.

    Article  PubMed  Google Scholar 

  7. Morrow M. Should routine breast cancer staging include MRI? Nat Clin Pract Oncol. 2009;6:72–3.

    Article  PubMed  Google Scholar 

  8. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106.

    Article  CAS  PubMed  Google Scholar 

  9. Vaidya JS, Joseph DJ, Tobias JS, Bulsara M, Wenz F, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet. 2010;376:91–102.

    Article  PubMed  Google Scholar 

  10. Vaidya JS, Baum M, Tobias JS, Morgan S, D’Souza D. The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer. Eur J Surg Oncol. 2002;28:447–54.

    Article  PubMed  Google Scholar 

  11. NSABP B-39, RTOG 0413: A Randomized Phase III Study of conventional whole breast irradiation versus partial breast irradiation for women with stage 0, I, or II breast cancer. Clin Adv Hematol Oncol. 2006;4:719–21.

    Google Scholar 

  12. Arthur DW, Winter K, Kuske RR, Bolton J, Rabinovitch R, et al. A Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95–17. Int J Radiat Oncol Biol Phys. 2008;72:467–73.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Vicini F, Winter K, Wong J, Pass H, Rabinovitch R, et al. Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/II breast carcinoma. Int J Radiat Oncol Biol Phys. 2010;77:1120–7.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Polgár C, Fodor J, Major T, Németh G, Lövey K, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma—5-year results of a randomized trial. Int J Radiat Oncol Biol Phys. 2007;69:694–702.

    Article  PubMed  Google Scholar 

  15. Valachis A, Mauri D, Polyzos NP, Mavroudis D, Georgoulias V, Casazza G. Partial breast irradiation or whole breast radiotherapy for early breast cancer: a meta-analysis of randomized controlled trials. Breast J. 2010;16:245–51.

    Article  PubMed  Google Scholar 

  16. Scanderbeg D, Yashar C, White G, Rice R, Pawlicki T. Evaluation of three APBI techniques under NSABP B-39 guidelines. J Appl Clin Med Phys. 2009;11:3021.

    PubMed  Google Scholar 

  17. Gupta S, Scanderbeg DJ, Kamrava M, Yashar CM. Unexpected toxicity in a patient treated with 3D conformal accelerated partial breast radiotherapy. Brachytherapy. 2009;8:207–9.

    Article  PubMed  Google Scholar 

  18. Jagsi R, Ben-David MA, Moran JM, Marsh RB, Griffith KA, et al. Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys. 2010; 76:71–8.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Hepel JT, Tokita M, MacAusland SG, Evans SB, Hiatt JR, et al. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2009;75:1290–6.

    Article  PubMed  Google Scholar 

  20. Taylor ME, Perez CA, Halverson KJ, Kuske RR, Philpott GW, et al. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys. 1995;31:753–64.

    Article  CAS  PubMed  Google Scholar 

  21. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363:1665–72.

    Article  PubMed  Google Scholar 

  22. Timmerman R, Galvin J, Michalski J, Straube W, Ibbott G, et al. Accreditation and quality assurance for Radiation Therapy Oncology Group: multicenter clinical trials using stereotactic body radiation therapy in lung cancer. Acta Oncol. 2006;45:779–86.

    Article  PubMed  Google Scholar 

  23. Nataf F, Schlienger M, Liu Z, Foulquier JN, Grès B, et al. Radiosurgery with or without a 2-mm margin for 93 single brain metastases. Int J Radiat Oncol Biol Phys. 2008;70:766–72.

    Article  PubMed  Google Scholar 

  24. Timmerman R, Abdulrahman R, Kavanagh BD, Meyer JL. Lung cancer: a model for implementing stereotactic body radiation therapy into practice. Front Radiat Ther Oncol. 2007;40:368–85.

    Article  PubMed  Google Scholar 

  25. Hadziahmetovic M, Loo BW, Timmerman RD, Mayr NA, Wang JZ, et al. Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer—updates of radiobiology, techniques, and clinical outcomes. Discov Med. 2010;9:411–7.

    PubMed  Google Scholar 

  26. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer. 2003;41:1–11.

    Article  PubMed  Google Scholar 

  27. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303:1070–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Timmerman RD. Surgery versus stereotactic body radiation therapy for early-stage lung cancer: who’s down for the count? J Clin Oncol. 2010;28:907–9.

    Article  PubMed  Google Scholar 

  29. Bondiau PY, Lallement M, Bahadoran P, Birtwisle-Peyrottes I, Chapellier C, et al. CyberKnife and neoadjuvant chemotherapy for breast tumors: preliminary results. Cancer Radiother. 2009;13: 79–84.

    Article  PubMed  Google Scholar 

  30. Bondiau PY, Bahadoran P, Lallement M, Birtwisle-Peyrottes I, Chapellier C, et al. Robotic stereotactic radioablation concomitant with neo-adjuvant chemotherapy for breast tumors. Int J Radiat Oncol Biol Phys. 2009;75:1041–7.

    Article  PubMed  Google Scholar 

  31. Yu XC. US National Cancer Institute 4R44CA132254-02; 2010.

    Google Scholar 

  32. Nichols EM, Dhople AA, Mohiuddin MM, Flannery TW, Yu CX, Regine WF. Comparative analysis of the post-lumpectomy target volume versus the use of pre-lumpectomy tumor volume for early-stage breast cancer: implications for the future. Int J Radiat Oncol Biol Phys. 2010;77:197–202.

    Article  PubMed  Google Scholar 

  33. Li X, Zhang J, Wang C, Yu C. Stereotactic radiation therapy for breast cancer: dosimetry feasibility. Int J Radiat Oncol Biol Phys. 2010;78:S139.

    Article  Google Scholar 

  34. Mutaf YD, Yu C, Zhang J, Prado K, Feigenberg S, et al. Dosimetric characterization of a novel stereotactic radiotherapy device for breast cancer. Radiother Oncol. 2011;99(S1):S160–1.

    Article  Google Scholar 

  35. Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1–2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985;56:979–90.

    Article  CAS  PubMed  Google Scholar 

  36. Faverly DR, Hendriks JH, Holland R. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements. Cancer. 2001;91:647–59.

    Article  CAS  PubMed  Google Scholar 

  37. Nichols EM, Feigenberg SJ, Marter K, Lasio G, Cheston SB, et al. Pre-operative therapy increases patient eligibility for accelerated partial breast irradiation (APBI) and decreases normal tissue exposure. Int J Radiat Oncol Biol Phys. 2010;78:S251.

    Article  Google Scholar 

  38. Yu C, Feigenberg S. Radiat Oncol (London, England). Rad. Onc.journal. 2011; 99:S305.

    Google Scholar 

  39. Nelson WR, Hirayama H, Rogers DW. Electron-photon transport using the EGS4 Monte Carlo code. Trans Am Nucl Soc. 1986;52:379–80.

    Google Scholar 

  40. Kawrakow I, Walters BR. Efficient photon beam dose calculations using DOSXYZnrc with BEAMnrc. Med Phys. 2006;33:3046–56.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA

    Yildirim D. Mutaf Ph.D., Cedric Yu D.Sc., Steven J. Feigenberg M.D. & William F. Regine M.D.

Authors
  1. Yildirim D. Mutaf Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cedric Yu D.Sc.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Steven J. Feigenberg M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. William F. Regine M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yildirim D. Mutaf Ph.D. .

Editor information

Editors and Affiliations

  1. Department of Neurosurgery, SUNY Upstate Medical University, Syracuse, USA

    Lawrence S. Chin

  2. Dept. of Radiation Oncology, Univ. of Maryland School of Medicine, Baltimore, Maryland, USA

    William F. Regine

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Mutaf, Y.D., Yu, C., Feigenberg, S.J., Regine, W.F. (2015). GammaPod. In: Chin, L., Regine, W. (eds) Principles and Practice of Stereotactic Radiosurgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8363-2_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8363-2_12

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8362-5

  • Online ISBN: 978-1-4614-8363-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation